Patient-Tailored Gilteritinib Triplet Therapy Shows Tolerability Gains in Relapsed FLT3-Mutated AML
A Swedish multicenter retrospective study of 29 patients suggests that shortening the period of concomitant azacitidine, venetoclax and gilteritinib exposure ...
